Skip to main content

Advertisement

Log in

Topical antibiotic prophylaxis before intravitreal injections: a pilot study

  • Medical Ophthalmology
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

This article has been updated

Abstract

Purpose

To explore whether topical antibiotic prophylaxis in patients scheduled for intravitreal injections achieves surface sterility in a greater proportion of subjects as compared to povidone-iodine alone.

Material and methods

A randomized, triple-blind clinical trial. Population: patients scheduled for intravitreal injections for maculopathy. Inclusion criteria: any sex and race, age 18 years and above. Subjects were randomized into 4 groups: the first group applied chloramphenicol (CHLORAM), the second netilmicin (NETILM), the third a commercial ozonized antiseptic solution (OZONE), and the fourth applied no drops (CONTROL). Outcome variable: percentage of non-sterile conjunctival swabs. Specimens were collected before and after the application of 5% povidone-iodine moments before the injection.

Results

Ninety-eight subjects (33.7% females, 64.3% males), mean age: 70.2 ± 9.3 years (54–91). Before povidone-iodine, both the CHLORAM and NETILM group showed a lower percentage of non-sterile swabs (61.1% and 31.3% respectively), as compared to the OZONE (83.3%) and CONTROL (86.5%) groups (p < .04). However, this statistical difference was lost after the application of povidone-iodine for 3 min. Percentage of non-sterile swabs in each group after applying 5% povidone-iodine: CHLORAM 11.1%, NETILM 12.5%, CONTROL 15.4%, OZONE 25.0%. This was not statistically significant (p > .05).

Conclusions

Topical antibiotic prophylaxis with chloramphenicol or netilmicin drops decreases the bacterial load on the conjunctiva. However, after the application of povidone-iodine, all groups showed a significant reduction in the percentage of non-sterile swabs, and this value was comparable among all groups. For this reason, authors conclude that povidone-iodine alone is sufficient and prior topical antibiotic prophylaxis is not indicated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Change history

  • 28 June 2023

    The given name and family name of the first author has been incorrectly identified in the XML version. This has been updated and corrected: "Edoardo" as given name and "Trovato Battagliola" as family name.

References

  1. Pacella E, Pacella F, La Torre G, Impallara D, Malarska K, Brillante C, Turchetti P, De Giusti M (2012) Testing the effectiveness of intravitreal ranibizumab during 12 months of follow-up in venous occlusion treatment. Clin Ter 163(6):e413–e422

    CAS  PubMed  Google Scholar 

  2. Casparis H, Wolfensberger TJ, Becker M, Eich G, Graf N, Ambresin A, Mantel I, Michels S (2014) Incidence of presumed endophthalmitis after intravitreal injection performed in the operating room: a retrospective multicenter study. (Retina Philadelphia, Pa) 34(1):12–17. https://doi.org/10.1097/IAE.0b013e31829f74b0

    Article  PubMed  Google Scholar 

  3. Freiberg FJ, Brynskov T, Munk MR, Sørensen TL, Wolf S, Wirth MA, Becker M, Michels S (2017) Low endophthalmitis rates after intravitreal anti-vascular endothelial growth factor injections in an operation room: a retrospective multicenter study. Retina (Philadelphia, Pa) 37(12):2341–2346. https://doi.org/10.1097/IAE.0000000000001488

    Article  CAS  PubMed  Google Scholar 

  4. Pacella F, Agostinelli E, Carlesimo SC, Nebbioso M, Secondi R, Forastiere M, Pacella E (2016) Management of anterior chamber dislocation of a dexamethasone intravitreal implant: a case report. J Med Case Reports 10(1):282. https://doi.org/10.1186/s13256-016-1077-2

    Article  Google Scholar 

  5. Pacella F, Pacella E, Trovato Battagliola E, Malvasi M, Scalinci SZ, Turchetti P, Salducci M, Lucchino L, & Arrico L (2021). Efficacy and safety of intravitreal fluocinolone acetonide microimplant (ILUVIEN®) in patients with chronic diabetic macular edema: 1 year follow-up. European journal of ophthalmology, 11206721211020203. Advance online publication. https://doi.org/10.1177/11206721211020203

  6. Morioka M, Takamura Y, Nagai K, Yoshida S, Mori J, Takeuchi M, Sawada T, Sone K, Fukuyama H, Kusuhara S, Yasukawa T, Murakami T, Tabuchi H, Nagasato D, Hirano T, Ueda T, Jujo T, Sasajima H, Mitamura Y, Ishikawa K, … Inatani M (2020). Incidence of endophthalmitis after intravitreal injection of an anti-VEGF agent with or without topical antibiotics. Sci Rep, 10(1), 22122. https://doi.org/10.1038/s41598-020-79377-w

  7. Torres-Costa S, Ramos D, Brandão E, Carneiro Â, Rosas V, Rocha-Sousa A, Falcão-Reis F, Falcão M (2021) Incidence of endophthalmitis after intravitreal injection with and without topical antibiotic prophylaxis. Eur J Ophthalmol 31(2):600–606. https://doi.org/10.1177/1120672120902028

    Article  PubMed  Google Scholar 

  8. Pacella E, Loffredo L, Malvasi M, TrovatoBattagliola E, Messineo D, Pacella F, Arrico L (2020) Effects of repeated intravitreal injections of dexamethasone implants on intraocular pressure: a 4-year study. Clinical ophthalmology (Auckland, NZ) 14:3611–3617. https://doi.org/10.2147/OPTH.S265691

    Article  CAS  Google Scholar 

  9. Hunyor AP, Merani R, Darbar A, Korobelnik JF, Lanzetta P, Okada AA (2018) Topical antibiotics and intravitreal injections. Acta Ophthalmol 96(5):435–441. https://doi.org/10.1111/aos.13417

    Article  PubMed  Google Scholar 

  10. Tanaka K, Shimada H, Mori R, Nakashizuka H, Hattori T, Okubo Y (2019) No increase in incidence of post-intravitreal injection endophthalmitis without topical antibiotics: a prospective study. Jpn J Ophthalmol 63(5):396–401. https://doi.org/10.1007/s10384-019-00684-5

    Article  CAS  PubMed  Google Scholar 

  11. Storey PP, Patel D, Garg S (2020) Endophthalmitis following intravitreal injection of anti-vascular endothelial growth factor agents Canadian journal of ophthalmology. Journal canadien d’ophtalmologie 55(4):286–292. https://doi.org/10.1016/j.jcjo.2020.01.015

    Article  PubMed  Google Scholar 

  12. Puustjärvi T, Teräsvirta M, Nurmenniemi P, Lokkila J, Uusitalo H (2006) Penetration of topically applied levofloxacin 0.5% and ofloxacin 0.3% into the vitreous of the non-inflamed human eye. Graefes Arch Clin Exp Ophthalmol= Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 244(12):1633–1637

    Article  PubMed  Google Scholar 

  13. Yalvac IS, Basci NE, Bozkurt A, Duman S (2003) Penetration of topically applied ciprofloxacin and ofloxacin into the aqueous humor and vitreous. J Cataract Refract Surg 29(3):487–491. https://doi.org/10.1016/s0886-3350(02)01538-9

    Article  PubMed  Google Scholar 

  14. Sakamoto H, Sakamoto M, Hata Y, Kubota T, Ishibashi T (2007) Aqueous and vitreous penetration of levofloxacin after topical and/or oral administration. Eur J Ophthalmol 17(3):372–376. https://doi.org/10.1177/112067210701700316

    Article  CAS  PubMed  Google Scholar 

  15. Cekic O, Batman C, Yasar U, Basci NE, Bozkurt A, Kayaalp SO (1998) Penetration of ofloxacin in human aqueous and vitreous humors following oral and topical administration. Retina (Philadelphia, Pa) 18(6):521–525. https://doi.org/10.1097/00006982-199806000-00005

    Article  CAS  PubMed  Google Scholar 

  16. Pacella E, La Torre G, Impallara D, Malarska K, Turchetti P, Brillante C, Smaldone G, De Paolis G, Muscella R, Pacella F (2013) Efficacy and safety of the intravitreal treatment of diabetic macular edema with pegaptanib: a 12-month follow-up. Clin Ter 164(2):e121–e126. https://doi.org/10.7417/CT.2013.1543

    Article  CAS  PubMed  Google Scholar 

  17. Kaldirim H, Yazgan S, Kirgiz A, Ozdemir B, Yilmaz A (2020) Effect of topical antibiotic prophylaxis on conjunctival flora and antibiotic resistance following intravitreal injections in patients with type 2 diabetes. Korean J Pphthalmol : KJO 34(4):265–273. https://doi.org/10.3341/kjo.2019.0144

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Storey P, Dollin M, Rayess N, Pitcher J, Reddy S, Vander J, Hsu J, Garg S, & Post-Injection Endophthalmitis Study Team (2016) The effect of prophylactic topical antibiotics on bacterial resistance patterns in endophthalmitis following intravitreal injection. Graefe’s Arch Clin Exp Ophthalmol Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 254(2):235–242. https://doi.org/10.1007/s00417-015-3035-x

    Article  CAS  Google Scholar 

  19. Pacella F, Collini S, Angelucci F, Agostinelli E, Guzzo AS, Cerza C, Pacella E (2017) Infections in hospital departments What is hospital responsibility? La Clinica terapeutica 168(4):e266–e270. https://doi.org/10.7417/T.2017.2018

    Article  CAS  PubMed  Google Scholar 

  20. Nelson RE, Hatfield KM, Wolford H, Samore MH, Scott RD, Reddy SC, Olubajo B, Paul P, Jernigan JA, Baggs J (2021) National estimates of healthcare costs associated with multidrug-resistant bacterial infections among hospitalized patients in the United States. Clin Infect Dis : Off Publ Infect Dis Soc Am 72(Suppl 1):S17–S26. https://doi.org/10.1093/cid/ciaa1581

    Article  Google Scholar 

  21. De Sio S, Letizia C, Petramala L, Saracino V, Cedrone F, Sanguigni P, Buomprisco G, Perri R, TrovatoBattagliola E, Mannocci A, La Torre G (2018) Work-related stress and cortisol levels: is there an association? Results of an observational study. Eur Rev Med Pharmacol Sci 22(24):9012–9017. https://doi.org/10.26355/eurrev_201812_16672

    Article  PubMed  Google Scholar 

  22. Lepelletier D, Maillard JY, Pozzetto B, Simon A (2020) Povidone iodine: properties, mechanisms of action, and role in infection control and Staphylococcus aureus Decolonization. Antimicrob Agents Chemother 64(9):e00682-e720. https://doi.org/10.1128/AAC.00682-20

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Stefanutti C, Mesce D, Pacella F, Di Giacomo S, Turchetti P, Forastiere M, TrovatoBattagliola E, La Torre G, Smaldone G, Pacella E (2019) Optical coherence tomography of retinal and choroidal layers in patients with familial hypercholesterolaemia treated with lipoprotein apheresis. Atheroscler Suppl 40:49–54. https://doi.org/10.1016/j.atherosclerosissup.2019.08.031

    Article  PubMed  Google Scholar 

  24. Avery RL, Bakri SJ, Blumenkranz MS, Brucker AJ, Cunningham ET Jr, DʼAmico DJ, Dugel PU, Flynn HW Jr, Freund KB, Haller JA, Jumper JM, Liebmann JM, McCannel CA, Mieler WF, Ta CN, & Williams GA (2014). Intravitreal injection technique and monitoring: updated guidelines of an expert panel. Retina (Philadelphia, Pa.), 34 Suppl 12, S1–S18. https://doi.org/10.1097/IAE.0000000000000399

  25. Bhatt SS, Stepien KE, Joshi K (2011) Prophylactic antibiotic use after intravitreal injection: effect on endophthalmitis rate. Retina (Philadelphia, Pa) 31(10):2032–2036. https://doi.org/10.1097/IAE.0b013e31820f4b4f

    Article  CAS  PubMed  Google Scholar 

  26. Abdolrahimzadeh S, Gharbiya M, Formisano M, Bertini F, Cerini A, Pacella E (2019) Anti-vascular endothelial growth factor intravitreal therapy and macular ganglion cell layer thickness in patients with neovascular age-related macular degeneration. Curr Eye Res 44(9):1000–1005. https://doi.org/10.1080/02713683.2019.1610179

    Article  CAS  PubMed  Google Scholar 

  27. Asghar A, Ellhai I, Obaid N, Sughra U (2018) Role of topical antibiotics in prophylaxis against endophthalmitis following intravitreal antibiotics. Pakistan J Med Sci 34(5):1283–1287. https://doi.org/10.12669/pjms.345.14817

    Article  Google Scholar 

  28. Cheung CS, Wong AW, Lui A, Kertes PJ, Devenyi RG, Lam WC (2012) Incidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injections. Ophthalmology 119(8):1609–1614. https://doi.org/10.1016/j.ophtha.2012.02.014

    Article  PubMed  Google Scholar 

  29. Patel SN, Gangaputra S, Sternberg P Jr, Kim SJ (2020) Prophylaxis measures for postinjection endophthalmitis. Surv Ophthalmol 65(4):408–420. https://doi.org/10.1016/j.survophthal.2019.12.005

    Article  PubMed  Google Scholar 

  30. Storey PP, Tauqeer Z, Yonekawa Y, Todorich B, Wolfe JD, Shah SP, Shah AR, Koto T, Abbey AM, Morizane Y, Sharma P, Wood EH, Morizane-Hosokawa M, Pendri P, Pancholy M, Harkey S, Jeng-Miller KW, Obeid A, Borkar DS, Chen E, … Post-Injection Endophthalmitis (PIE) Study Group (2019). The impact of prefilled syringes on endophthalmitis following intravitreal injection of ranibizumab. Am J Ophthalmol, 199, 200–208. https://doi.org/10.1016/j.ajo.2018.11.023

  31. Merani R, McPherson ZE, Luckie AP, Gilhotra JS, Runciman J, Durkin S, Muecke J, Donaldson M, Aralar A, Rao A, Davies PE (2016) Aqueous chlorhexidine for intravitreal injection antisepsis: a case series and review of the literature. Ophthalmology 123(12):2588–2594. https://doi.org/10.1016/j.ophtha.2016.08.022

    Article  PubMed  Google Scholar 

  32. Oakley CL, Vote BJ (2016) Aqueous chlorhexidine (0.1%) is an effective alternative to povidone-iodine for intravitreal injection prophylaxis. Acta ophthalmologica 94(8):e808–e809. https://doi.org/10.1111/aos.12981

    Article  CAS  PubMed  Google Scholar 

  33. Shimada H, Hattori T, Mori R, Nakashizuka H, Fujita K, Yuzawa M (2013) Minimizing the endophthalmitis rate following intravitreal injections using 0.25% povidone-iodine irrigation and surgical mask. Graefes Arch Clin Exp Ophthalmol Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 251(8):1885–1890. https://doi.org/10.1007/s00417-013-2274-y

    Article  CAS  PubMed  Google Scholar 

  34. McDonnell G, Russell AD (1999) Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev 12(1):147–179. https://doi.org/10.1128/CMR.12.1.147

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

Edoardo, Trovato Battagliola, MD: Writing—original draft.

Rodolfo Javier, Riveros Cabral, MD: Data curation.

Gregorio Manco, MD: Project administration.

Gianluca Puggioni: Investigation, data curation.

Claudio Brancato, MD: Investigation, data curation.

Pietro Mangiantini, MD: Formal analysis.

Floriana Testa, MD: Visualization.

Mariaelena Malvasi, MD: Visualization.

Giammarco Raponi, MD: Supervision.

Paolo Turchetti, MD: Methodology.

Fernanda Pacella, MD. Methodology.

Elena Pacella, MD: Conceptualization, writing—review and editing, supervision.

Corresponding author

Correspondence to Elena Pacella.

Ethics declarations

Ethical approval

This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Sapienza University of Rome (Nov. 8th, 2021/No. 345235).

Informed consent

Informed consent was obtained from all individual participants included in the study.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Trovato Battagliola, E., Riveros Cabral, R.J., Manco, G. et al. Topical antibiotic prophylaxis before intravitreal injections: a pilot study. Graefes Arch Clin Exp Ophthalmol 261, 2953–2959 (2023). https://doi.org/10.1007/s00417-023-06113-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-023-06113-1

Keywords

Navigation